Cardiovascular diseases among patients with schizophrenia.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Asian Journal of Psychiatry

• Publication date

  2016-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.ajp.2015.11.012PMID 26957335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE CANADIAN JOURNAL OF PSYCHIATRY

  2017cited by this paper
• National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

  2015cited by this paper
• Standard cardiovascular disease risk algorithms underestimate the risk of cardiovascular disease in schizophrenia: evidence from a national primary care database.

  2014influential reference
• Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression.

  2014cited by this paper
• Effect of Acetaldehyde Intoxication and Withdrawal on NPY Expression: Focus on Endocannabinoidergic System Involvement

  2014cited by this paper
• Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions

  2014cited by this paper
• Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries

  2013cited by this paper
• A meta‐analysis of cardio‐metabolic abnormalities in drug naïve, first‐episode and multi‐episode patients with schizophrenia versus general population controls

  2013cited by this paper
• Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors.

  2013cited by this paper
• Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia

  2013influential reference
• Adult Medication-Free Schizophrenic Patients Exhibit Long-Chain Omega-3 Fatty Acid Deficiency: Implications for Cardiovascular Disease Risk

  2013cited by this paper
• Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins

  2013cited by this paper
• The dietary pattern of patients with schizophrenia: a systematic review.

  2013cited by this paper
• Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis

  2013cited by this paper
• Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study

  2013cited by this paper
• Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2013cited by this paper
• A clustered randomised trial examining the effect of social marketing and community mobilisation on the age of uptake and levels of alcohol consumption by Australian adolescents

  2013cited by this paper
• A meta-analysis of cardio-metabolic abnormalities in drug naive, first-epidode and multi-episode patients with schizophrenia versus general population controls, Russian version

  2013cited by this paper
• Tissue Doppler imaging for diagnosis of coronary artery disease: a systematic review and meta-analysis

  2012cited by this paper
• A systematic review of correlates of physical activity in patients with schizophrenia

  2012cited by this paper
• Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011.

  2012cited by this paper
• Effects of exercise therapy on cardiorespiratory fitness in patients with schizophrenia.

  2012cited by this paper
• Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

  2011cited by this paper
• Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia.

  2011cited by this paper
• 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

  2011cited by this paper
• Effects of high aerobic intensity training in patients with schizophrenia—A controlled trial

  2011influential reference
• Mortality in schizophrenia: a measurable clinical endpoint

  2010cited by this paper
• Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

  2010cited by this paper
• THE RISK OF MALIGNANCY

  2010cited by this paper
• Common and Unique Biological Pathways Associated with Smoking Initiation/Progression, Nicotine Dependence, and Smoking Cessation

  2010cited by this paper
• Understanding cardiovascular disease through the lens of genome-wide association studies.

  2009cited by this paper
• Mortality and tardive dyskinesia: long-term study using the US National Death Index.

  2009cited by this paper
• Atypical antipsychotic drugs and the risk of sudden cardiac death.

  2009cited by this paper
• Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.

  2009cited by this paper
• 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

  2009cited by this paper
• Obesity among those with mental disorders: a National Institute of Mental Health meeting report.

  2009cited by this paper
• Physical fitness matters more than physical activity in controlling cardiovascular disease risk factors

  2009cited by this paper
• Schizophrenia and physical health problems

  2009cited by this paper
• Schizophrenia and breast cancer incidence: a systematic review of clinical studies.

  2009cited by this paper
• Cancer mortality in patients with schizophrenia

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• The omega-3 index: From biomarker to risk marker to risk factor

  2009cited by this paper
• Mortality Rates Among Patients With Schizophrenia and Tardive Dyskinesia

  2009cited by this paper
• Cancer incidence in patients with schizophrenia and their first‐degree relatives – a meta‐analysis

  2008cited by this paper
• Social inequality and incidence of and survival from lung cancer in a population-based study in Denmark, 1994-2003.

  2008cited by this paper
• Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues.

  2008cited by this paper
• Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005.

  2008cited by this paper
• Pharmacological treatment of severe dyslipidaemia in patients with schizophrenia

  2007cited by this paper
• Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.

  2007cited by this paper
• Mortality among persons with schizophrenia in Sweden: An epidemiological study

  2007cited by this paper
• Health habits of patients with schizophrenia

  2007cited by this paper
• A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?

  2007cited by this paper
• Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia.

  2007cited by this paper
• Validation of a physical activity assessment tool for individuals with schizophrenia.

  2006cited by this paper
• Clinical Practice and Epidemiology in Mental Health Prevalence of Diabetes, Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia over the Course of the Illness: a Cross-sectional Study

  2006cited by this paper
• Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.

  2006cited by this paper
• Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder.

  2006cited by this paper
• A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study.

  2005cited by this paper
• EFFECTS OF EXERCISE ON MENTAL AND PHYSICAL HEALTH PARAMETERS OF PERSONS WITH SCHIZOPHRENIA

  2005cited by this paper
• Smoking initiation and schizophrenia: a replication study in a Spanish sample.

  2005cited by this paper
• Schizophrenia and increased risks of cardiovascular disease.

  2005cited by this paper
• Size of burden of schizophrenia and psychotic disorders.

  2005cited by this paper
• A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors.

  2005influential reference
• Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

  2005cited by this paper
• Antipsychotics and the risk of sudden cardiac death.

  2004cited by this paper
• Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia.

  2004cited by this paper
• Omega 3 fatty acids for prevention and treatment of cardiovascular disease.

  2004influential reference
• Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.

  2003cited by this paper
• Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

  2003cited by this paper
• Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients.

  2003cited by this paper
• Use of drugs, alcohol and tobacco by people with schizophrenia: case–control study

  2002influential reference
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics.

  2002cited by this paper
• Minimizing the Risks Associated with Significant QTc Prolongation in People with Schizophrenia: A Consensus Statement by The Cardiac Safety in Schizophrenia Group

  2002cited by this paper
• Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

  2002influential reference
• [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].

  2002cited by this paper
• The world health report 2001 - Mental health: new understanding, new hope

  2001cited by this paper
• Antipsychotics and the risk of sudden cardiac death.

  2001cited by this paper
• Mortality and causes of death in schizophrenia in Stockholm county, Sweden.

  2000cited by this paper
• Mortality in a Cohort of Patients with Vibration Syndrome in Japan

  2000cited by this paper
• The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors

  2000cited by this paper
• Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates

  2000cited by this paper
• Importance of n-3 fatty acids in health and disease.

  2000cited by this paper
• Causes of the excess mortality of schizophrenia.

  2000cited by this paper
• Mental disorders and use of cardiovascular procedures after myocardial infarction.

  2000cited by this paper
• Suicide in schizophrenia: risk factors and clozapine treatment.

  1998cited by this paper
• Excess mortality of mental disorder

  1998cited by this paper
• Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

  1997cited by this paper
• Excess mortality of schizophrenia

  1997cited by this paper
• Omega‐3 fatty acid supplementation in schizophrenic patients

  1996cited by this paper
• Schizophrenia: recent epidemiologic issues.

  1995cited by this paper
• Mortality and Causes of Death in First Admitted Schizophrenic Patients

  1993cited by this paper
• Mortality rates.

  1991cited by this paper

• Serum Apolipoprotein B Levels and Apolipoprotein B/Apolipoprotein A1 Ratio as Predictors of Dyslipidemia Risk in Patients Treated with Second-Generation Antipsychotics: A Retrospective Cohort Study

  2025cites this paper
• Repurposed antihypertensive drugs for negative symptoms in schizophrenia: A systematic review and meta‐analysis

  2025cites this paper
• 2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee.

  2025cites this paper
• Research on comorbidity characteristics and patterns of hospitalized participants with schizophrenia in China

  2025cites this paper
• Schizophrenia, bipolar disorder and major depressive disorder are probably not risk factors for cardiovascular disease: A Mendelian randomized study.

  2025cites this paper
• Coping strategies in patients with schizophrenia and concomitant chronic cardiovascular diseases

  2024cites this paper
• Prevalence of metabolic syndrome and its associated factors in first‐treatment drug‐naïve schizophrenia patients: A large‐scale cross‐sectional study

  2024cites this paper
• A novel ECG-based approach for classifying psychiatric disorders: Leveraging wavelet scattering networks.

  2024cites this paper
• Age-related variations in heart rate variability profiles among patients with schizophrenia and major depressive disorder

  2024cites this paper
• Breast cancer risk among women with schizophrenia and association with duration of antipsychotic use: population-based cohort study in South Korea

  2024cites this paper
• Profile of inpatients with psychotic disorders referred to the consultation–liaison psychiatry unit in a general hospital in South India

  2024cites this paper
• Associations between antipsychotics and the risk of incident cardiovascular diseases in individuals with schizophrenia: a nested case–control study

  2023cites this paper
• Cardiac healthcare disparities and electrocardiography (ECG) differences in schizophrenia at end of life.

  2023cites this paper
• Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications

  2023cites this paper
• Comparison of frontal QRS-T angle and inflammatory parameters between the patients with drug-naive first episode psychosis and healthy controls.

  2023cites this paper
• Is Dosage Adjustment for Olanzapine Really Necessary?

  2023cites this paper
• Association between Empathy and Clinical Symptoms among Overweight and Non-Overweight Chinese Chronic Schizophrenia Patients

  2023cites this paper
• A Systematic Review on the Potential of Aspirin to Reduce Cardiovascular Risk in Schizophrenia

  2023cites this paper
• Comparison of frontal QRS-T angle in patients with schizophrenia and healthy volunteers.

  2022cites this paper
• A novel ternary pattern-based automatic psychiatric disorders classification using ECG signals

  2022cites this paper
• Influence of cardiovascular risk factors on the cognitive functions of schizophrenia patients

  2022cites this paper
• Gambaran Kelainan Cardiovascular pada Pasien Schizophrenia: Literature Review

  2022cites this paper
• Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia

  2022cites this paper
• Sex differences in the blood-brain barrier: implications for mental health.

  2022cites this paper
• Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: A systematic review and network meta-analysis

  2021cites this paper
• Prevalence and correlates of metabolic syndrome and its components in adults with psychotic disorders in Eldoret, Kenya

  2021cites this paper
• The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia

  2021cites this paper
• Proposing a causal pathway for health-related quality of life in people with psychotic disorders.

  2021cites this paper
• [Schizophrenia and cardiometabolic disorders].

  2021cites this paper
• Convolutional neural network in proteomics and metabolomics for determination of comorbidity between cancer and schizophrenia

  2021cites this paper
• Relationship of metabolic parameters with the course of the first episode of psychosis - preliminary research.

  2021cites this paper
• The Outcomes of Acute Coronary Syndrome in Patients Suffering From Schizophrenia: A Systematic Review

  2021cites this paper
• Medical Comorbidities in 181 Patients With Bipolar Disorder vs. Schizophrenia and Related Psychotic Disorders: Findings From a Single-Center, Retrospective Study From an Acute Inpatients Psychiatric Unit

  2021cites this paper
• Schizophrenia and Hospital Admissions for Cardiovascular Events in a Large Population: The APNA Study

  2021cites this paper
• Peer-delivered services and peer support reaching people with schizophrenia: A scoping review

  2021cites this paper
• Dietary Habits and Obesity in Patients with Psychotic Disorders in Rural Areas in Northwestern Greece

  2021cites this paper
• Time Trends in the Use of Coronary Procedures, Guideline-Based Therapy, and All-Cause Mortality following the Acute Coronary Syndrome in Patients with Schizophrenia

  2020cites this paper
• Interaction between the immune and metabolic systems in different stages of schizophrenia spectrum disorders

  2020cites this paper
• A Review on the Relationship between Nutrition, Diet and Mental Health

  2020cites this paper
• A common variation in HCN1 is associated with heart rate variability in schizophrenia.

  2020cites this paper
• Prevalence of obesity and clinical and metabolic correlates in first-episode schizophrenia relative to healthy controls

  2020cites this paper
• The Prevalence Of Metabolic Disorders And Their Associated Risk Factors In Forensic Patients With Schizophrenia Spectrum Disorders On Clozapine Compared To Haloperidol At Valkenberg Hospital

  2019influential citation
• EFFECT OF PROTEIN MALNUTRITION ON MENTAL HEALTH AND ITS DEVELOPMENT.

  2019cites this paper
• Verbesserung der Arzneimitteltherapiesicherheit von Antipsychotika und Beta-Adrenozeptor-Antagonisten durch Therapeutisches Drug Monitoring und Untersuchungen zu pharmakokinetischen Interaktionen

  2019cites this paper
• Experiences of Hospitalization of Patients With Psychotic Disorders on Medical–Surgical Units: A Thematic Analysis

  2019cites this paper
• Physical Comorbidity and Causes of Death Among Schizophrenia Patients: A Retrospective Descriptive Study

  2019cites this paper
• Non-Psychiatric Hospitalization For Patients With Psychotic Disorders: A Mixed-Methods Study

  2019cites this paper
• Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders.

  2019cites this paper
• Cardiovascular Risk and Metabolic Syndrome in Individuals with Mental Disorders

  2019cites this paper
• Tobacco smoking and nicotine dependence in first episode and established psychosis.

  2019cites this paper
• Ruptured Superior Mesenteric Artery Aneurysm due to Fibromuscular Dysplasia: A Rare Vascular Presentation in a Patient with Schizophrenia.

  2019cites this paper
• Coronary artery disease and schizophrenia: the interplay of heart and mind.

  2019cites this paper
• Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?

  2019cites this paper
• Herzinsuffizienz: Psychopathologische Interdependenzen und psychosoziale Relevanz Œ eine kommentierte Übersichtsarbeit // Heart failure: psychopathological interdependencies and psychosocial relevance. A critical narrative review

  2019cites this paper
• 10-year CVD risk in Han Chinese mainland patients with schizophrenia.

  2018cites this paper
• Herzinsuffizienz : Psychopathologische Interdependenzen und psychosoziale Relevanz – eine kommentierte

  2018cites this paper
• Comparative study of quality of life and metabolic syndrome in schizophrenia patients who are receiving treatment versus antipsychotic naïve, first episode patients from a tertiary care hospital.

  2018cites this paper
• The Crisis of Poor Physical Health and Early Mortality of Psychiatric Patients

  2018cites this paper
• The effect of schizophrenia on major adverse cardiac events, length of hospital stay, and prevalence of somatic comorbidities following acute coronary syndrome

  2018cites this paper
• Positive mental health in schizophrenia and healthy comparison groups: relationships with overall health and biomarkers

  2018cites this paper
• Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis.

  2017cites this paper
• Serum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study

  2017cites this paper
• Treatment following myocardial infarction in patients with schizophrenia

  2017influential citation
• Cost-effectiveness of 3-month paliperidone treatment for chronic schizophrenia in Spain

  2017cites this paper
• METABOLISMO DO TRIPTOFANO EM TRANSTORNOS MENTAIS: UM ENFOQUE NA ESQUIZOFRENIA

  2017cites this paper
• Statins as an Adjuvant Therapy for Psychotic Disorders: Current Evidence with a Systematic Overview of Double-Blind Placebo Controlled Trials

  2017cites this paper
• Systematic Review of Epigenetic Effects of Pharmacological Agents for Bipolar Disorders

  2017cites this paper
• Heart disease and mortality in patients with serious mental illness: Prevention is key.

  2016cites this paper
• Nutritional Factors Affecting Mental Health

  2016influential citation
• Metabolic syndrome and its relationship with negative symptoms in female patients with schizophrenia

  2016cites this paper